Lv12
45 积分 2021-08-29 加入
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system
2小时前
已完结
Sensory neurons drive immune exclusion by stimulating a dense extracellular matrix in the breast cancer tumor microenvironment
20小时前
已完结
Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy
20小时前
已完结
Explaining the Relationships Between Age, Endocrine Therapy Persistence, and Risk of Recurrence in Hormone Receptor-Positive Early Breast Cancer: A Nationwide Cohort Study
5天前
已完结
Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer
5个月前
已完结
Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
5个月前
已完结
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
5个月前
已完结
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
5个月前
已完结
Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer
6个月前
已完结
Ribociclib plus Endocrine Therapy in Early Breast Cancer
7个月前
已完结
皖公网安备34019202002308
